Skip to main content
AkademIndex

Products

For developers

AkademBaseOpen API for the ecosystem
← Back to work

Works cited by this work

264 works

Work: The emerging microbiome‐based approaches to <scp>IBD</scp> therapy: From <scp>SCFAs</scp> to urolithin A

  1. Colonic Health: Fermentation and Short Chain Fatty Acids

    Julia MW Wong, Russell J. de Souza, Cyril W.C. Kendall +2

    Review article20065 citations
    ABI

  2. Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases

    Daniela Parada Venegas, Marjorie K. De la Fuente, Glauben Landskron +6

    Review article20194 citations
    ABI

  3. A possible pathogenic role of Syndecan-1 in the pathogenesis of coronavirus disease 2019 (COVID-19)

    Sajad Karampoor, Hamid Zahednasab, Mohammad Farahmand +9

    Article20214 citations
    ABI

  4. Symbiotic Bacterial Metabolites Regulate Gastrointestinal Barrier Function via the Xenobiotic Sensor PXR and Toll-like Receptor 4

    Madhukumar Venkatesh, Subhajit Mukherjee, Hongwei Wang +16

    Article20143 citations
    ABI

  5. Immunopathogenesis of IBD: current state of the art

    Heitor Siffert Pereira de Souza, Claudio Fiocchi

    Review article20153 citations
    ABI

  6. Review article: the role of butyrate on colonic function

    Henrike M. Hamer, Daisy Jonkers, Koen Venema +3

    Review article20073 citations
    ABI

  7. Dual role of microbiota-derived short-chain fatty acids on host and pathogen

    Rasoul Mirzaei, Elahe Dehkhodaie, Behnaz Bouzari +6

    Review article20213 citations
    ABI

  8. Immunometabolism in biofilm infection: lessons from cancer

    Rasoul Mirzaei, Niloofar Sabokroo, Yaghoub Ahmadyousefi +2

    Review article20223 citations
    ABI

  9. Role of the gut microbiota in inflammatory bowel disease pathogenesis: What have we learnt in the past 10 years?

    Georgina L. Hold

    Review article20143 citations
    ABI

  10. The emerging role of 27-hydroxycholesterol in cancer development and progression: An update

    Saade Abdalkareem Jasim, Hamzah H. Kzar, Mohammed Hayder Hamad +9

    Review articleCholesterol and Lipid MetabolismInternational Immunopharmacology20222 citations
    ABI

  11. Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases

    Henri Duboc, Sylvie Rajca, Dominique Rainteau +21

    Article20122 citations
    ABI

  12. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn’s disease

    Arlette Darfeuille–Michaud, Jérôme Boudeau, P. Bulois +7

    Article20042 citations
    ABI

  13. Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota

    Koji Atarashi, Takeshi Tanoue, Kenshiro Oshima +19

    Article20132 citations
    ABI

  14. Gut microbiota-derived metabolites as key actors in inflammatory bowel disease

    Aonghus Lavelle, Harry Sokol

    Review article20202 citations
    ABI

  15. Short‐chain fatty acid topical treatment in distal ulcerative colitis

    Piero Vernia, Adriana Marcheggiano, R. Caprilli +6

    Article19952 citations
    ABI

  16. Short-chain fatty acids induce both effector and regulatory T cells by suppression of histone deacetylases and regulation of the mTOR–S6K pathway

    Jason Y. Park, Myunghoo Kim, Seung Goo Kang +4

    Article20142 citations
    ABI

  17. The Microbiome and Butyrate Regulate Energy Metabolism and Autophagy in the Mammalian Colon

    Dallas R. Donohoe, Nikhil Garge, Xinxin Zhang +4

    Article20112 citations
    ABI

  18. Treatment of Diversion Colitis with Short-Chain-Fatty Acid Irrigation

    James M. Harig, Konrad H. Soergel, Richard Komorowski +1

    Article19892 citations
    ABI

  19. Regulation of immune cell function by short‐chain fatty acids

    Renan Oliveira Corrêa, José Luís Fachi, Aline Vieira +2

    Review article20162 citations
    ABI

  20. Microbiota metabolite short chain fatty acids, GPCR, and inflammatory bowel diseases

    Mingming Sun, Wei Wu, Zhanju Liu +1

    Review article20162 citations
    ABI

  21. Gut Microbial Metabolites Fuel Host Antibody Responses

    Myunghoo Kim, Yaqing Qie, Jeongho Park +1

    Article20162 citations
    ABI

  22. Microbiota metabolite short-chain fatty acid acetate promotes intestinal IgA response to microbiota which is mediated by GPR43

    Wei Wu, Mingming Sun, F. Chen +9

    Article20162 citations
    ABI

  23. The emerging role of probiotics as a mitigation strategy against coronavirus disease 2019 (COVID-19)

    Rasoul Mirzaei, Adeleh Attar, Saher Papizadeh +12

    Review article20212 citations
    ABI

  24. Fecal Lactate and Ulcerative Colitis

    Piero Vernia, R. Caprilli, Giovanni Latella +3

    Article19882 citations
    ABI

  25. Gut biogeography of the bacterial microbiota

    Gregory P. Donaldson, S. Melanie Lee, Sarkis K. Mazmanian

    Review article20152 citations
    ABI